Stock Scorecard



Stock Summary for Cytek BioSciences Inc (CTKB) - $6.01 as of 4/18/2024 6:21:35 PM EST

Total Score

12 out of 29

Currently on the following lists
None
Tim's Recommendation
Avoid

Growth List Algorithm Criteria for CTKB

Positive earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for CTKB

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for CTKB

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2

Bonus Criteria for CTKB

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Latest News for for CTKB

Cytek Biosciences ( CTKB ) Loses -7.27% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner 4/11/2024 1:35:00 PM
Wall Street Analysts Believe Cytek Biosciences ( CTKB ) Could Rally 47.61%: Here's is How to Trade 4/10/2024 1:55:00 PM
Is it a Good Idea to Invest in ADMA Biologics ( ADMA ) Stock Now? 4/9/2024 3:07:00 PM
Notice convening the Annual General Meeting in BioPorto A/S 4/4/2024 9:07:00 AM
New Strong Buy Stocks for April 2nd 4/2/2024 11:05:00 AM
Cytek® Biosciences Opens New Facility to Address Increasing Global Demand for Cutting-Edge Cell Analysis Solutions - Cytek Biosciences ( NASDAQ:CTKB ) 3/7/2024 10:30:00 PM
Tesla, Spirit Airlines, New York Community Bancorp And Other Big Stocks Moving Lower On Monday - Tesla ( NASDAQ:TSLA ) , New York Community ( NYSE:NYCB ) 3/4/2024 3:40:00 PM
Cytek Biosciences Reports Fourth Quarter and Full Year 2023 Financial Results and Provides 2024 Outlook 2/28/2024 10:05:00 PM
ANI Pharmaceuticals ( ANIP ) Earnings Expected to Grow: What to Know Ahead of Next Week's Release 2/22/2024 3:00:00 PM
Earnings Preview: Cytek Biosciences, Inc. ( CTKB ) Q4 Earnings Expected to Decline 2/21/2024 3:00:00 PM

Financial Details for CTKB

Company Overview

Ticker CTKB
Company Name Cytek BioSciences Inc
Country USA
Description N/A
Sector Name LIFE SCIENCES
Industry Name LABORATORY ANALYTICAL INSTRUMENTS
Most Recent Quarter 12/31/2023
Next Earnings Date 5/6/2024

Stock Price History

Last Day Price 6.01
Last Day Price Updated 4/18/2024 6:21:35 PM EST
Last Day Volume 709,569
Average Daily Volume 816,868
52-Week High 12.31
52-Week Low 3.80
Last Price to 52 Week Low 58.16%

Valuation Measures

Trailing PE N/A
Industry PE 28.90
Sector PE 61.34
5-Year Average PE 26.29
Free Cash Flow Ratio 4.70
Industry Free Cash Flow Ratio 100.20
Sector Free Cash Flow Ratio 30.17
Current Ratio Most Recent Quarter 6.97
Total Cash Per Share 1.28
Book Value Per Share Most Recent Quarter 3.01
Price to Book Ratio 2.05
Industry Price to Book Ratio 801.96
Sector Price to Book Ratio 22.08
Price to Sales Ratio Twelve Trailing Months 4.18
Industry Price to Sales Ratio Twelve Trailing Months 4.44
Sector Price to Sales Ratio Twelve Trailing Months 5.19

Share Statistics

Total Shares Outstanding 130,824,000
Market Capitalization 786,252,240
Institutional Ownership N/A

Dividends

Ex-Dividend Date N/A
Last Dividend Amount 0.00
Current Dividend Amount 0.00
Dividend Aristocrat? False
Trailing Annual Dividend Rate 0.00
Trailing Annual Dividend Yield 0.00%
Forward Annual Dividend Rate 0.00
Forward Annual Dividend Yield 0.00%
5-Year Dividend Payments Count 0
3-Year Average Dividend Yield 0.00%
5-Year Average Dividend Yield 0.00%
1-Year Dividend Growth Rate Percentage 0.00%
3-Year Dividend Growth Rate Percentage 0.00%
5-Year Dividend Growth Rate Percentage 0.00%
All-Time Dividend Growth Rate Percentage 0.00%
Dividend Payout Ratio N/A

Income Statement

Quarterly Earnings Growth YOY 65.80%
Annual Earnings Growth -589.05%
Reported EPS 12 Trailing Months -0.09
Reported EPS Past Year 0.00
Reported EPS Prior Year -0.09
Net Income Twelve Trailing Months -12,148,000
Net Income Past Year -12,148,000
Net Income Prior Year 2,484,000
Quarterly Revenue Growth YOY 20.50%
5-Year Revenue Growth 840.74%

Balance Sheet

Total Cash Most Recent Quarter 167,299,000
Total Cash Past Year 167,299,000
Total Cash Prior Year 296,601,000
Net Cash Position Most Recent Quarter 165,086,000
Net Cash Position Past Year 165,086,000
Long Term Debt Past Year 2,213,000
Long Term Debt Prior Year 2,851,000
Total Debt Most Recent Quarter 2,213,000
Equity to Debt Ratio Past Year 0.99
Equity to Debt Ratio Most Recent Quarter 0.99
Total Stockholder Equity Past Year 393,064,000
Total Stockholder Equity Prior Year 425,546,000
Total Stockholder Equity Most Recent Quarter 393,064,000

Options

Put/Call Ratio 0.00
Has Options Options Chain
Liquidity Rating

Technical Analysis

Yahoo Finance Chart Yahoo Finance Chart
MACD -0.31
MACD Signal -0.32
20-Day Bollinger Lower Band 5.74
20-Day Bollinger Middle Band 7.85
20-Day Bollinger Upper Band 9.95
Beta 1.37
RSI 37.45
50-Day SMA 7.56
200-Day SMA 0.00

System

Modified 4/17/2024 10:07:46 PM EST